ADCT EBITDA Margin
Adc Therapeutics Sa · EBITDA Margin
ADCT EBITDA Margin
Latest reported-111.21%period ending
ADCT TTM EBITDA Margin (-10962.63% → -111.21%)
TTM ebitda margin
High-resolution chart · PNG
ADCT ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -111.2092% | |
| -105.7417% | |
| -108.212% | |
| -150.4926% | |
| -149.4343% | |
| -127.168% | |
| -145.6089% | |
| -166.1369% | |
| -180.8168% | |
| -204.0601% | |
| -221.5216% | |
| -108.309% | |
| -75.5122% | |
| -84.2326% | |
| -54.8731% | |
| -95.098% | |
| -185.53% | |
| -233.1692% | |
| -673.1875% | |
| -1,391.0747% | |
| -5,021.8085% | |
| -6,677.9052% | |
| -3,612.516% | |
| -3,226.7296% | |
| -3,010.2276% | |
| -5,931.189% | |
| -10,962.6316% |